Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data

Simple item page
dc.contributor.authorSoyer, Nur
dc.contributor.authorTurgut, Mehmet
dc.contributor.authorHaznedaroğlu, İbrahim
dc.contributor.authorYılmaz, Fergün
dc.contributor.authorAydoğdu, İsmet
dc.contributor.authorPir, Ali
dc.contributor.authorKarakuş, Volkan
dc.contributor.authorÖzgür, Gökhan
dc.contributor.authorKis, C.
dc.contributor.authorCeran, Funda
dc.contributor.authorİlhan, Gül
dc.contributor.authorÖzkan, Melda
dc.contributor.authorArslaner, M.
dc.contributor.authorİnce, İdris
dc.contributor.buuauthorAli, Rıdvan
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Dahiliye Bilim Dalı.tr_TR
dc.date.accessioned2024-01-08T06:47:36Z
dc.date.available2024-01-08T06:47:36Z
dc.date.issued2018-10
dc.descriptionBu çalışma, 17-20, Ekim 2018 tarihlerinde İstanbul[Türkiye]’de düzenlenen 9. International Eurasian Hematology Oncology Congress (EHOC) Kongresi‘nde bildiri olarak sunulmuştur.tr_TR
dc.identifier.citationSoyer, N. vd. (2018). ''Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data''. Leukemia Research, 73(Supplement 1), S46-S46.en_US
dc.identifier.endpageS46tr_TR
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.issueSupplement 1en_US
dc.identifier.startpageS46tr_TR
dc.identifier.urihttps://hdl.handle.net/11452/38816
dc.identifier.volume73tr_TR
dc.identifier.wos000447176600107tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.wosSCIE
dc.indexed.wosCPCIS
dc.language.isoenen_US
dc.publisherPergamo-Elsevier Sciens Ltden_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalLeukemia Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOncologyen_US
dc.subjectHematologyen_US
dc.subject.wosOncologyen_US
dc.subject.wosHematologyen_US
dc.titleRetrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated dataen_US
dc.typeArticleen_US
dc.wos.quartileQ2

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science